A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who smoke have a greater annual rate of decline in forced expiratory volume in 1 s (FEV1) than those patients who have stopped smoking.
Saved in:
Main Authors: | Charles KN Chan, François Maltais, Chris Sigouin, Jennifer M Haddon, Gordon T Ford, on behalf of the SAFE Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2007/192961 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003
by: Denis E O’donnell, et al.
Published: (2003-01-01) -
State of the Art Compendium: Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease
by: Denis E O’Donnell, et al.
Published: (2004-01-01) -
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
by: Denis E O’Donnell, et al.
Published: (2007-01-01) -
Managing Dyspnea in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Canadian Thoracic Society Clinical Practice Guideline
by: Darcy D Marciniuk, et al.
Published: (2011-01-01) -
Optimizing Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease – Practical Issues: A Canadian Thoracic Society Clinical Practice Guideline
by: Darcy D Marciniuk, et al.
Published: (2010-01-01)